BIOCOM, Inc. is a life science association. The company focuses on initiatives that influence the region’s life science community in the development and delivery of products, as well as on capital formation, public policy, workforce development, group purchasing, and member services, such as networking events. It represents life sciences communities in Southern California. The company was founded in 1991 and is based in San Diego, California with an additional office in Los Angeles, California.
4510 Executive Drive
San Diego, CA 92121
Founded in 1991
Biocom Announces Board Appointments
Jun 7 16
Biocom announced the appointment of 13 new directors to its board, including the appointment of Charles Dadswell, senior vice president and general counsel for Illumina, and Rich Pascoe, chief executive officer of Apricus Biosciences, to the executive committee of Biocom's board. In addition, Biocom announced that Magda Marquet, Ph.D., co-founder of Ajinomoto Althea and AltheaDx, and Brent D. Jacobs, executive director in the global life sciences practice group at Cushman & Wakefield, were named as life directors, a prestigious and special class of director. At Illumina, Mr. Dadswell is SVP, general counsel & secretary. He has worldwide responsibility for all legal, government affairs, and intellectual property matters. Before joining Illumina, Mr. Dadswell was vice president, general counsel for North and Latin America and corporate director of global intellectual property at bioMerieux. Mr. Pascoe joined Apricus as CEO in March of 2013 following the merger of Somaxon Pharmaceuticals, where he had served as chief executive officer since August 2008, with Pernix. The additional new members of the board are: Bruno Buisson, Ph.D., founder, general manager and chief scientist, Neuroservice; Peter Callstrom, president and CEO, San Diego Workforce Partnership; Sunita "Sunny" Cooke, Ph.D., superintendent/president, Mira Costa College; Carol Cox, executive vice president, strategy, corporate development and external affairs, NuVasive; J. David Enloe, Jr., president and CEO, Althea; James Mackay, Ph.D., president and chief operating officer, Ardea Biosciences/AstraZeneca; Steven R. Pacelli, executive vice president, strategy and corporate development, Dexcom; Dean Samsvick, partner in charge, Southern California life science practice, KPMG; Stephen Welter, Ph.D., vice president for research and dean of graduate affairs, San Diego State University; Kenneth Weixel, managing partner, San Diego, Deloitte & Touche LLP; Matthew Williams, vice president, state government affairs, AbbVie.
Biocom Establishes Los Angeles Office; Appoints Dina Lozofsky as Executive Director of the New Office
Apr 18 16
Biocom announced the launch of its Los Angeles operations and the appointment of Dina Lozofsky as executive director of the new office. Biocom's goal in Los Angeles is to accelerate the growth of a thriving, dynamic life sciences community, leveraging the many building blocks already in place. Nearly 300 biopharmaceutical and medical device companies call Los Angeles County home, in addition to some of the nation's finest teaching hospitals and biomedical research organizations. The area also boasts a highly skilled talent pool of life science graduates, many with advanced degrees. Biocom'sLos Angeles office will work closely with Biocom's cadre of existing members in Los Angeles county, as well as other key industry stakeholders, to identify the unique needs and opportunities of the region. Ms. Lozofsky brings more than two decades of experience in the science and technology industries of Southern California, where she has specialized in transferring ideas from academic institutions to entrepreneurs, and in commercializing those technologies once they are brought in house. Most recently, she served as associate director for licensing and business development at University of California, Santa Barbara's Office of Technology and Industry Alliances, where she designed, launched and led a program to mentor and support startup companies formed around UCSB technology.
BIOCOM, Inc. Presents at 14th Annual BIO Investor Forum, Oct-20-2015
Oct 16 15
BIOCOM, Inc. Presents at 14th Annual BIO Investor Forum, Oct-20-2015 . Venue: Parc 55 Hotel, San Francisco, California, United States.